COVID-19 Medicines: Antivirals & Supportive Care

Medicines in the Covid-19 Support category

Rivaroxaban Tablets

Rivaroxaban

10mg

Indicated to address blood clot risk and supported to mitigate thromboembolic complications.

From$0.85/ tabletView

Molnunat

Molnupiravir

200mg

Intended to target viral replication in COVID-19, designed to alleviate clinical symptoms and support recovery in patients with mild-to-moderate infection.

From$158.10/ bottleView

Dexone

Dexamethasone

0.5mg

Intended to mitigate severe inflammatory responses and allergic conditions.

From$0.43/ tabletView

Ofev

Nintedanib

100mg

Developed to target idiopathic pulmonary fibrosis to alleviate breathing difficulties.

From$3.90/ capsuleView

Esbriet

Pirfenidone

200 · 400mg

Utilized to manage idiopathic pulmonary fibrosis to alleviate lung fibrosis progression.

From$2.18/ tabletView

What’s in this category

Oral antiviral molnupiravir is used early in selected cases.
Supportive treatments such as the steroid dexamethasone and the anticoagulant rivaroxaban are used in specific situations.
Lung fibrosis treatments like nintedanib and pirfenidone.

Conditions it covers

These medicines are used for covid 19 and idiopathic pulmonary fibrosis.

COVID-19 Support in Asia

Asia sat at the centre of the COVID-19 response, and the region built strong systems for testing, treatment and antiviral access. Oral antivirals and supportive treatments remain relevant for higher-risk groups across Asian markets.